INS and type 2 diabetes mellitus: In their study, 50 patients with resistant hypertension were divided into RDN group (N = 37) and conventional treatment group (N = 13), of whom 20 (40%) were T2DM under metformin, glicazide, or combined therapy, while none was under insulin treatment.